Wong N - Search Results

1

Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms.

Chen H, Gao F, He M, Ding XF, Wong AM, Sze SC, Yu AC, Sun T, Chan AW, Wang X, Wong N. Chen H, et al. Among authors: wong am, wong n. Hepatology. 2019 Sep;70(3):1011-1025. doi: 10.1002/hep.30500. Epub 2019 Mar 22. Hepatology. 2019. PMID: 30637779 Free PMC article.

2

Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.

Wong N, Chan A, Lee SW, Lam E, To KF, Lai PB, Li XN, Liew CT, Johnson PJ. Wong N, et al. J Hepatol. 2003 Mar;38(3):298-306. doi: 10.1016/s0168-8278(02)00412-9. J Hepatol. 2003. PMID: 12586295

3

Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma.

Chan KY, Lai PB, Squire JA, Beheshti B, Wong NL, Sy SM, Wong N. Chan KY, et al. Among authors: wong nl, wong n. Mod Pathol. 2006 Dec;19(12):1546-54. doi: 10.1038/modpathol.3800674. Epub 2006 Sep 15. Mod Pathol. 2006. PMID: 16980951 Free article.

4

A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.

Poon TC, Wong N, Lai PB, Rattray M, Johnson PJ, Sung JJ. Poon TC, et al. Among authors: wong n. Gastroenterology. 2006 Oct;131(4):1262-70. doi: 10.1053/j.gastro.2006.08.014. Epub 2006 Aug 10. Gastroenterology. 2006. PMID: 17030195

5

RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma.

Cheng AS, Wong N, Tse AM, Chan KY, Chan KK, Sung JJ, Chan HL. Cheng AS, et al. Among authors: wong n. Cancer Lett. 2007 Aug 8;253(1):43-52. doi: 10.1016/j.canlet.2007.01.004. Epub 2007 Feb 12. Cancer Lett. 2007. PMID: 17296261

6

Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells.

Pang EY, Bai AH, To KF, Sy SM, Wong NL, Lai PB, Squire JA, Wong N. Pang EY, et al. Among authors: wong nl, wong n. Hepatology. 2007 Aug;46(2):436-45. doi: 10.1002/hep.21691. Hepatology. 2007. PMID: 17559150

7

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N. Wong QW, et al. Among authors: wong n. Gastroenterology. 2008 Jul;135(1):257-69. doi: 10.1053/j.gastro.2008.04.003. Epub 2008 Apr 11. Gastroenterology. 2008. PMID: 18555017

8

Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis.

Cheng IK, Ching AK, Chan TC, Chan AW, Wong CK, Choy KW, Kwan M, Lai PB, Wong N. Cheng IK, et al. Among authors: wong ck, wong n. J Pathol. 2010 Feb;220(3):348-60. doi: 10.1002/path.2644. J Pathol. 2010. PMID: 19927314

9

MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.

Wong QW, Ching AK, Chan AW, Choy KW, To KF, Lai PB, Wong N. Wong QW, et al. Among authors: wong n. Clin Cancer Res. 2010 Feb 1;16(3):867-75. doi: 10.1158/1078-0432.CCR-09-1840. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103675

10

Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma.

Law PT, Wong N. Law PT, et al. Among authors: wong n. J Gastroenterol Hepatol. 2011 Mar;26(3):437-49. doi: 10.1111/j.1440-1746.2010.06512.x. J Gastroenterol Hepatol. 2011. PMID: 21332540 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,520 results

Search Page

Filters